Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Classical hematology 1

Conditions

Nasopharyngeal Carcinoma 20Squamous Cell Carcinoma of Head and Neck 7Oropharyngeal Neoplasms 7Prostatic Neoplasms 5Carcinoma 4Rectal Neoplasms 3Nasopharyngeal Neoplasms 3Mouth Neoplasms 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Stomatitis 2Pancreatic Adenocarcinoma 2Neoplasm Metastasis 2Meningeal Carcinomatosis 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Tumor Virus Infections 1Thyroid Carcinoma, Anaplastic 1Stomatognathic Diseases 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Sarcoma 1Recurrence 1

Interventions

iron isomaltoside 1000 1ferric derisomaltose 1Radiotherapy, Intensity-Modulated 1Population Groups 1Niferex 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Anemia × Radiotherapy, Intensity-Modulated × Clear all
NCT05913414 2023-06-22

Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 2 Recruiting
120 enrolled
Classical hematologyHead & Neck

Nasopharyngeal Carcinoma, Anemia, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡